{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:11:18Z","timestamp":1719792678938},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,29]]},"DOI":"10.7759\/cureus.63480","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:44:49Z","timestamp":1719708289000},"source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Small Cell Carcinoma of the Bladder Complicated by Paraneoplastic Acute Thrombocytopenia"],"prefix":"10.7759","author":[{"given":"Ao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Farnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narangoda","family":"Shyamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni S","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017, 71:96-108. 10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2003.04893.x","article-title":"Small cell carcinoma of the bladder","volume":"94","author":"Sved P","year":"2004","unstructured":"Sved P, Gomez P, Manoharan M, et al.. Small cell carcinoma of the bladder. BJU Int. 2004, 94:12-7.","journal-title":"BJU Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15146","article-title":"Primary small cell carcinoma of the bladder","volume":"13","author":"Kassas JM","year":"2021","unstructured":"Kassas JM, Fiuk JV, Brenner CA. Primary small cell carcinoma of the bladder. Cureus. 2021, 13:e15146. 10.7759\/cureus.15146","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.02.001","article-title":"Management of thrombocytopenia in cancer","volume":"164 Suppl 1","author":"Castaman G","year":"2018","unstructured":"Castaman G, Pieri L. Management of thrombocytopenia in cancer. Thromb Res. 2018, 164 Suppl 1:S89-93. 10.1016\/j.thromres.2018.02.001","journal-title":"Thromb Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2011.02.004","article-title":"Paraneoplastic autoimmune thrombocytopenia in solid tumors","volume":"81","author":"Krauth MT","year":"2012","unstructured":"Krauth MT, Puthenparambil J, Lechner K. Paraneoplastic autoimmune thrombocytopenia in solid tumors. Crit Rev Oncol Hematol. 2012, 81:75-81. 10.1016\/j.critrevonc.2011.02.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.09.001","article-title":"Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder","volume":"4","author":"Fischer-Valuck BW","year":"2018","unstructured":"Fischer-Valuck BW, Rao YJ, Henke LE, et al.. Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder. Eur Urol Focus. 2018, 4:900-6. 10.1016\/j.euf.2017.09.001","journal-title":"Eur Urol Focus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200%2FJCO.2008.19.0256","article-title":"Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide\/doxorubicin and etoposide\/cisplatin in small-cell urothelial cancer","volume":"27","author":"Siefker-Radtke AO","year":"2009","unstructured":"Siefker-Radtke AO, Kamat AM, Grossman HB, et al.. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide\/doxorubicin and etoposide\/cisplatin in small-cell urothelial cancer. J Clin Oncol. 2009, 27:2592. 10.1200%2FJCO.2008.19.0256","journal-title":"J Clin Oncol"},{"key":"ref8","article-title":"Pancytopenia and neuroendocrine small cell carcinoma of the bladder","volume":"1","author":"Ab\u00e1igar-Pedraza I","year":"2016","unstructured":"Ab\u00e1igar-Pedraza I, Caballero-Romeu JP, Costa E, et al.. Pancytopenia and neuroendocrine small cell carcinoma of the bladder. Clin Oncol. 2016, 1:1114.","journal-title":"Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.09.010","article-title":"Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies","volume":"122","author":"Nagrebetsky A","year":"2019","unstructured":"Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP. Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth. 2019, 122:19-31. 10.1016\/j.bja.2018.09.010","journal-title":"Br J Anaesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.10.003","article-title":"Neuroendocrine carcinoma of unknown primary site","volume":"36","author":"Spigel DR","year":"2009","unstructured":"Spigel DR, Hainsworth JD, Greco FA. Neuroendocrine carcinoma of unknown primary site. Semin Oncol. 2009, 36:52-9. 10.1053\/j.seminoncol.2008.10.003","journal-title":"Semin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0110","article-title":"Distance as a barrier to cancer diagnosis and treatment: review of the literature","volume":"20","author":"Ambroggi M","year":"2015","unstructured":"Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist. 2015, 20:1378-85. 10.1634\/theoncologist.2015-0110","journal-title":"Oncologist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2007.168","article-title":"Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia","volume":"7","author":"Chan RC","year":"2007","unstructured":"Chan RC, Hundemer GL, Tatsas A, Cookson MS. Urothelial carcinoma of the bladder metastatic to bone marrow presenting as isolated thrombocytopenia. ScientificWorldJournal. 2007, 7:1000-3. 10.1100\/tsw.2007.168","journal-title":"ScientificWorldJournal"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(07)70143-3","article-title":"Cancer, thrombosis and heparin-induced thrombocytopenia","volume":"2","author":"Prandoni P","year":"2007","unstructured":"Prandoni P, Falanga A, Piccioli A. Cancer, thrombosis and heparin-induced thrombocytopenia. Thromb Res. 2007, 2:137-40. 10.1016\/S0049-3848(07)70143-3","journal-title":"Thromb Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4910-956","article-title":"Amoxicillin\/clavulanic acid-induced thrombocytopenia","volume":"49","author":"Mansour H","year":"2014","unstructured":"Mansour H, Saad A, Azar M, Khoueiry P. Amoxicillin\/clavulanic acid-induced thrombocytopenia. Hosp Pharm. 2014, 49:956-60. 10.1310\/hpj4910-956","journal-title":"Hosp Pharm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.01.027","article-title":"Paraneoplastic thrombocytopenia","volume":"134","author":"Kalas V","year":"2021","unstructured":"Kalas V, Johnson-Sasso C, Morency EG, Ji P, Manesh R, Patel AA. Paraneoplastic thrombocytopenia. Am J Med. 2021, 134:976-9. 10.1016\/j.amjmed.2021.01.027","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.12.012","article-title":"Response to pembrolizumab in a patient with chemotherapy refractory bladder cancer with small cell variant histology: a case report and review of the literature","volume":"15","author":"Wilde L","year":"2017","unstructured":"Wilde L, Ali SM, Solomides CC, Ross JS, Trabulsi E, Hoffman-Censits J. Response to pembrolizumab in a patient with chemotherapy refractory bladder cancer with small cell variant histology: a case report and review of the literature. Clin Genitourin Cancer. 2017, 15:e521-4. 10.1016\/j.clgc.2016.12.012","journal-title":"Clin Genitourin Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.04.020","article-title":"Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center","volume":"64","author":"Lynch SP","year":"2013","unstructured":"Lynch SP, Shen Y, Kamat A, et al.. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. 2013, 64:307-13. 10.1016\/j.eururo.2012.04.020","journal-title":"Eur Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265687-metastatic-small-cell-carcinoma-of-the-bladder-complicated-by-paraneoplastic-acute-thrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:44:54Z","timestamp":1719708294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265687-metastatic-small-cell-carcinoma-of-the-bladder-complicated-by-paraneoplastic-acute-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.63480","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}